Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 14 de 14
Filter
Add more filters










Publication year range
2.
S Afr Med J ; 111(3): 198-202, 2021 01 28.
Article in English | MEDLINE | ID: mdl-33944737

ABSTRACT

Recent studies have shown that the detection of SARS-CoV-2 genetic material in wastewater may provide the basis for a surveillance system to track the environmental dissemination of this virus in communities. An effective wastewater-based epidemiology (WBE) system may prove critical in South Africa (SA), where health systems infrastructure, testing capacity, personal protective equipment and human resource capacity are constrained. In this proof-of-concept study, we investigated the potential of SARS-CoV-2 RNA surveillance in untreated wastewater as the basis for a system to monitor COVID-19 prevalence in the population, an early warning system for increased transmission, and a monitoring system to assess the effectiveness of interventions. The laboratory confirmed the presence (qualitative analysis) and determined the RNA copy number of SARS-CoV-2 viral RNA by reverse transcription polymerase chain reaction (quantitative) analysis from 24-hour composite samples collected on 18 June 2020 from five wastewater treatment plants in Western Cape Province, SA. The study has shown that a WBE system for monitoring the status and trends of COVID-19 mass infection in SA is viable, and its development and implementation may facilitate the rapid identification of hotspots for evidence-informed interventions.


Subject(s)
RNA, Viral/isolation & purification , SARS-CoV-2/isolation & purification , Wastewater/virology , COVID-19/epidemiology , Environmental Monitoring , Epidemiological Monitoring , Humans , Pneumonia, Viral/epidemiology , Proof of Concept Study , South Africa/epidemiology
3.
Physiol Res ; 67(5): 813-818, 2018 11 14.
Article in English | MEDLINE | ID: mdl-30044119

ABSTRACT

Metformin is the first line therapy of type 2 diabetics, but continued reduction of their life expectancy warrants further investigation into alternative treatment strategies. This study reports on the combinational use of metformin with aspalathin, a C-glucosyl dihydrochalcone with known glucose lowering and antioxidant properties, as an effective hypoglycemic therapy in a type 2 diabetic (db/db) mouse model. When tested as a monotherapy, a low dose of aspalathin (13 mg/kg) showed no effect, while a high dose (130 mg/kg) has already displayed a better potential than metformin in protecting against diabetes associated symptoms in db/db mice. Thus, it remains of interest to determine whether this dihydrochalcone can improve the efficacy of metformin. The results showed that this combination therapy was more effective than the use of metformin as a monotherapy in ameliorating diabetes associated symptoms, including abnormal raised fasting plasma glucose levels, impaired glucose tolerance, as well as excessively increased body weights and fat content. The treated mice also had reduced food and water consumption when compared to untreated controls, with a pronounced effect evident in the last week of treatment. Therefore, this study supports further investigations into the ameliorative effect of combination therapy of metformin and aspalathin against diabetes associated symptoms.


Subject(s)
Aspalathus , Chalcones/administration & dosage , Diabetes Mellitus, Type 2/drug therapy , Hypoglycemic Agents/administration & dosage , Metformin/administration & dosage , Animals , Chalcones/isolation & purification , Diabetes Mellitus, Type 2/blood , Drug Synergism , Flavonoids/administration & dosage , Flavonoids/isolation & purification , Hypoglycemic Agents/isolation & purification , Male , Mice , Mice, Inbred C57BL , Mice, Transgenic
4.
Life Sci ; 180: 160-170, 2017 Jul 01.
Article in English | MEDLINE | ID: mdl-28478263

ABSTRACT

Doxorubicin is a highly effective, first line chemotherapeutic agent used in the management of hematological and solid tumors. The effective use of doxorubicin in cancer therapy has been severely limited owing to its well-documented cardiotoxic side effect. Oxidative stress, lipid peroxidation, apoptosis as well as dysregulation of autophagy, has been implicated as a major contributor associated with doxorubicin-induced cardiotoxicity. Increased oxidative stress and lipid peroxidation are known to enhance the production of reactive oxygen species, while autophagy has been reported to protect the cell from stress stimuli or, alternatively, contribute to cell death. Nonetheless, to date, no single chemical synthesized drug is available to prevent the harmful action of doxorubicin without reducing its anti-cancer efficacy. Therefore, the search for an effective and safe antagonist of doxorubicin-induced cardiotoxicity remains a challenge. In recent years, there has been much interest in the role plant-derived polyphenols play in the regulation of oxidative stress and autophagy. Therefore, the present review renders a concise overview of the mechanism associated with doxorubicin-induced cardiotoxicity as well as giving insight into the role plant-derived phytochemical play as a possible adjunctive therapy against the development of doxorubicin-induced cardiotoxicity.


Subject(s)
Cardiotoxicity/prevention & control , Doxorubicin/adverse effects , Polyphenols/pharmacology , Animals , Antibiotics, Antineoplastic/administration & dosage , Antibiotics, Antineoplastic/adverse effects , Apoptosis/drug effects , Autophagy/drug effects , Cardiotoxicity/etiology , Doxorubicin/administration & dosage , Humans , Lipid Peroxidation/drug effects , Oxidative Stress/drug effects , Reactive Oxygen Species/metabolism
5.
Phytomedicine ; 21(5): 595-601, 2014 Apr 15.
Article in English | MEDLINE | ID: mdl-24268738

ABSTRACT

Diabetic cardiomyopathy (DCM) is a disorder of the heart muscle that contributes to cardiovascular deaths in the diabetic population. Excessive generation of free radicals has been directly implicated in the pathogenesis of DCM. The use of antioxidants, through dietary supplementation, to combat increased cellular oxidative stress has gained popularity worldwide. Aspalathus linearis (rooibos) is a popular herbal tea that contains a novel antioxidant, aspalathin. Literature has reported on the antidiabetic, anti-inflammatory and free radical scavenging effects of rooibos. However, its protective effect against DCM has not been established. Therefore, this study investigated whether chronic exposure to an aqueous extract of fermented rooibos (FRE) has an ex vivo cardioprotective effect on hearts obtained from streptozotocin (STZ) induced diabetic rats. Adult Wistar rats were injected with 40 mg/kg of STZ. Two weeks after STZ injection, cardiomyocytes were isolated and cultured. Cultured cardiomyocytes were treated with FRE (1 and 10 µg/ml), vitamin E (50 µg/ml), and n-acetyl cysteine (1mM) for 6h, before exposure to either hydrogen peroxide (H2O2) or an ischemic solution. Cardiomyocytes exposed to H2O2 or an ischemic solution showed a decrease in metabolic activity and glutathione content with a concomitant increase in apoptosis and intracellular reactive oxygen species. Pretreatment with FRE was able to combat these effects and the observed amelioration was better than the known antioxidant vitamin E. This study provides evidence that an aqueous extract of fermented rooibos protects cardiomyocytes, derived from diabetic rats, against experimentally induced oxidative stress and ischemia.


Subject(s)
Aspalathus , Diabetic Cardiomyopathies/drug therapy , Myocytes, Cardiac/drug effects , Oxidative Stress/drug effects , Plant Extracts/therapeutic use , Animals , Apoptosis/drug effects , Cells, Cultured , Drug Evaluation, Preclinical , Fermentation , Glutathione/metabolism , Male , Myocardial Ischemia/drug therapy , Myocytes, Cardiac/metabolism , Phytotherapy , Plant Extracts/pharmacology , Rats , Rats, Wistar , Reactive Oxygen Species/analysis
6.
Phytomedicine ; 20(10): 813-9, 2013 Jul 15.
Article in English | MEDLINE | ID: mdl-23639187

ABSTRACT

Increased levels of free fatty acids (FFAs), specifically saturated free fatty acids such as palmitate are associated with insulin resistance of muscle, fat and liver. Skeletal muscle, responsible for up to 80% of the glucose disposal from the peripheral circulation, is particularly vulnerable to increased levels of saturated FFAs. Rooibos (Aspalathus linearis) and its unique dihydrochalcone C-glucoside, aspalathin, shown to reduce hyperglycemia in diabetic rats, could play a role in preventing or ameliorating the development of insulin resistance. This study aims to establish whether rooibos can ameliorate experimentally-induced insulin-resistance in C2C12 skeletal muscle cells. Palmitate-induced insulin resistant C2C12 cells were treated with an aspalathin-enriched green (unfermented) rooibos extract (GRE), previously shown for its blood glucose lowering effect in vitro and in vivo or an aqueous extract of fermented rooibos (FRE). Glucose uptake and mitochondrial activity were measured using 2-deoxy-[³H]-D-glucose, MTT and ATP assays, respectively. Expression of proteins relevant to glucose metabolism was analysed by Western blot. GRE contained higher levels of all compounds, except the enolic phenylpyruvic acid-2-O-glucoside and luteolin-7-O-glucoside. Both rooibos extracts increased glucose uptake, mitochondrial activity and ATP production. Compared to FRE, GRE was more effective at increasing glucose uptake and ATP production. At a mechanistic level both extracts down-regulated PKC θ activation, which is associated with palmitate-induced insulin resistance. Furthermore, the extracts increased activation of key regulatory proteins (AKT and AMPK) involved in insulin-dependent and non-insulin regulated signalling pathways. Protein levels of the glucose transporter (GLUT4) involved in glucose transport via these two pathways were also increased. This in vitro study therefore confirms that rooibos can ameliorate palmitate-induced insulin resistance in C2C12 skeletal muscle cells. Inhibition of PKC θ activation and increased activation of AMPK and AKT offer a plausible mechanistic explanation for this ameliorative effect.


Subject(s)
Aspalathus , Insulin Resistance/physiology , Muscle, Skeletal/cytology , Muscle, Skeletal/drug effects , Palmitic Acid/therapeutic use , Phytotherapy , Plant Extracts/therapeutic use , Animals , Aspalathus/chemistry , Cell Line , Hyperinsulinism/chemically induced , Hyperinsulinism/drug therapy , Mice , Muscle, Skeletal/enzymology , Palmitic Acid/pharmacology , Plant Extracts/pharmacology
7.
Phytomedicine ; 20(1): 32-9, 2012 Dec 15.
Article in English | MEDLINE | ID: mdl-23083813

ABSTRACT

Rooibos, an endemic South African plant, known for its use as herbal tea, has potential as an antidiabetic herbal product, following recent demonstration of the glucose lowering effect of its major flavonoid, the dihydrochalcone C-glucoside aspalathin. The purpose of this study was to confirm antidiabetic activity for rooibos extract high in aspalathin content. An extract (SB1) was selected after screening for high aspalathin content and α-glucosidase inhibition activity. On-line HPLC-biochemical detection confirmed α-glucosidase inhibitory activity for aspalathin. In vitro the extract induced a dose response increase in glucose uptake (5 × 10⁻5 to 5 µg/ml) on C2C12 myotubules. Aspalathin was effective at 1, 10 and 100 µM, while rutin was effective at 100 µM. In the Chang cells only the extract was effective. In vivo the extract sustained a glucose lowering effect comparable to metformin over a 6h period after administration (25mg/kg body weight (BW)) to STZ-induced diabetic rats. In an oral glucose tolerance test the extract (30 mg/kg BW) was more effective than vildagliptin (10mg/kg BW), a dipeptidyl peptidase-4 inhibitor. An aspalathin-rutin mixture (1:1; m/m) dosed at 1.4 mg/kg BW, but not the single compounds separately, reduced blood glucose concentrations of STZ-induced diabetic rats over a 6h monitoring period. The improved hypoglycemic activity of the aspalathin-rutin mixture and the extract illustrated synergistic interactions of polyphenols in complex mixtures.


Subject(s)
Aspalathus/chemistry , Blood Glucose/metabolism , Chalcones/therapeutic use , Diabetes Mellitus, Experimental/drug therapy , Hypoglycemic Agents/therapeutic use , Phytotherapy , Plant Extracts/therapeutic use , Adamantane/analogs & derivatives , Adamantane/pharmacology , Animals , Cell Line , Chalcones/pharmacology , Diabetes Mellitus, Experimental/blood , Dipeptidyl-Peptidase IV Inhibitors/pharmacology , Dose-Response Relationship, Drug , Drug Synergism , Glucose Tolerance Test , Glycoside Hydrolase Inhibitors , Hypoglycemic Agents/pharmacology , Male , Nitriles/pharmacology , Plant Extracts/pharmacology , Pyrrolidines/pharmacology , Rats , Rats, Wistar , Rutin/pharmacology , Rutin/therapeutic use , Vildagliptin
8.
J Ethnopharmacol ; 143(1): 372-6, 2012 Aug 30.
Article in English | MEDLINE | ID: mdl-22800680

ABSTRACT

ETHNOPHARMACOLOGICAL RELEVANCE: Communities in Chilumba, Malawi use herbal tea prepared from Fadogia ancylantha Schweinf (Rubiaceae) leaves for the management of diabetes, hypertension and alleviation of symptoms of gastrointestinal disorders and pneumonia. The objective of the study was to evaluate the in vitro antidiabetic, anti-oxidant and antimicrobial activities of the crude extracts of the leaves prepared by using three different extraction methods. MATERIALS AND METHODS: Each of the organic, cold and hot aqueous extracts of the herbal tea was evaluated for its effect on glucose uptake in C2C12 muscle and Chang cell lines. Metformin and insulin were used as positive controls. The anti-oxidant activity, based on neutralisation of DPPH free radicals, was determined spectrophotometrically. The Agar serial dilution method was utilised to determine the minimum inhibitory concentration (MIC) of the extracts for the selected fungal and bacterial strains. RESULTS AND DISCUSSION: The organic extract (12.5µg/ml) exhibited the highest in vitro glucose uptake increases in Chang cells (181.24±0.29%) and C2C12 muscle cells (172.29±0.32%) while the hot and cold aqueous extracts gave lower uptakes, 145.94±0.37% and 138.70±0.52% in Chang cells respectively. At 100µg/ml, aqueous extracts gave significantly higher (p<0.01) anti-oxidant activity (range 85.78-86.29%) than their organic counterpart (68.16%). The minimum inhibitory concentration (156µg/ml) was obtained in the organic extract against the fungus Aspergillus fumigatus and moderate growth inhibition was observed with other test micro-organisms. The hot aqueous extract inhibited the growth of all test organisms except Pseudomonas aeruginosa. The cold aqueous extract was inactive against Pseudomonas aeruginosa and Candida albicans. The differences in the MIC values between the aqueous extracts seem to suggest that raised temperatures, as traditionally practised, facilitate the extraction of secondary bioactive metabolites. CONCLUSION: These results show that Fadogia ancylantha extracts have high antidiabetic and anti-oxidant properties.


Subject(s)
Anti-Bacterial Agents/pharmacology , Antifungal Agents/pharmacology , Antioxidants/pharmacology , Glucose/metabolism , Hypoglycemic Agents/pharmacology , Plant Extracts/pharmacology , Rubiaceae , Aspergillus/drug effects , Aspergillus/growth & development , Aspergillus fumigatus/drug effects , Aspergillus fumigatus/genetics , Candida albicans/drug effects , Candida albicans/growth & development , Cell Line , Malawi , Microbial Sensitivity Tests , Pseudomonas/drug effects , Pseudomonas/growth & development
9.
Phytomedicine ; 19(8-9): 730-6, 2012 Jun 15.
Article in English | MEDLINE | ID: mdl-22516895

ABSTRACT

Athrixia phylicoides DC. is an aromatic shrub indigenous to the eastern parts of Southern Africa. Indigenous communities brew "bush tea" from dried twigs and leaves of A. phylicoides, which is consumed as a beverage and used for its medicinal properties. Plant polyphenols have been shown to be beneficial to Type 2 diabetes mellitus (T2D) and obesity. Aqueous extracts of the plant have been shown to be rich in polyphenols, in particular phenolic acids, which may enhance glucose uptake and metabolism. The aim of this study was to determine the phenolic composition of a hot water A. phylicoides extract and assess its in vitro effect on cellular glucose utilisation. The most abundant phenolic compounds in the extract were 6-hydroxyluteolin-7-O-glucoside, chlorogenic acid, protocatechuic acid, a di-caffeoylquinic acid and a methoxy-flavonol derivative. The extract increased glucose uptake in C2C12, Chang and 3T3-L1 cells, respectively. Intracellular glucose was utilised by both oxidation (C2C12 myocytes and Chang cells; p < 0.01 and p < 0.05, respectively) and by increased glycogen storage (Chang cells; p < 0.05). No cytotoxicity was observed in Chang cells at the concentrations tested. The effects of the extract were not dose-dependent. A. phylicoides aqueous extract stimulated in vitro glucose uptake and metabolism, suggesting that consumption of this phenolic-rich extract could potentially ameliorate metabolic disorders related to obesity and T2D.


Subject(s)
Asteraceae/chemistry , Glucose/metabolism , Plant Extracts/chemistry , Plant Extracts/pharmacology , 3T3-L1 Cells/drug effects , Africa, Southern , Animals , Chlorogenic Acid/analysis , Dose-Response Relationship, Drug , Drug Evaluation, Preclinical , Glucose/pharmacokinetics , Glycogen/metabolism , Hydroxybenzoates/analysis , Luteolin/analysis , Mice , Phenols/analysis , Phenols/chemistry , Plants, Medicinal/chemistry , Quinic Acid/analogs & derivatives
10.
Neuroscience ; 137(2): 619-25, 2006.
Article in English | MEDLINE | ID: mdl-16310967

ABSTRACT

Early exposure to adverse experiences may lead to specific changes in hippocampal glucocorticoid function resulting in abnormalities within the hypothalamic-adrenal axis. Given interactions between the neuroendocrine and central serotonergic systems, we hypothesized that exposure to early trauma would lead to abnormal hypothalamic-adrenal axis activity that would be normalized by pretreatment with a selective serotonin re-uptake inhibitor. Hypothalamic-adrenal axis function was assessed by determining basal corticosterone levels and hippocampal glucocorticoid receptor immunoreactivity. Rats were subjected to a triple stressor on postnatal day 28, and again to a single swim re-stress session on postnatal day 35 and postnatal day 60. On postnatal day 61 i.e. 24 h after the last re-stress, trunk blood was collected for serum corticosterone determinations and hippocampal tissue was collected for immunohistochemistry of glucocorticoid receptors. Escitalopram (5mg/kg) or saline vehicle was administered from postnatal day 47-postnatal day 60 via osmotic mini-pumps. Animals exposed to early life trauma showed an increase in basal corticosterone levels, and a significant decrease in the ratio of glucocorticoid receptor positive cells to total cells in the hilus, granule cell layer and the dentate gyrus. Both the increase in basal corticosterone and decrease in glucocorticoid receptor immunoreactivity were reversed by escitalopram pretreatment. These data confirm alterations in hypothalamic-adrenalaxis function that may stem from decreases in glucocorticoid receptor levels, in response to early adverse experiences, and demonstrate that these alterations are reversed by serotonin re-uptake inhibitor pretreatment.


Subject(s)
Aging/physiology , Citalopram/pharmacology , Dentate Gyrus/growth & development , Dentate Gyrus/metabolism , Down-Regulation/physiology , Receptors, Glucocorticoid/metabolism , Stress, Psychological/metabolism , Animals , Dentate Gyrus/drug effects , Disease Models, Animal , Down-Regulation/drug effects , Glucocorticoids/blood , Glucocorticoids/metabolism , Hypothalamo-Hypophyseal System/drug effects , Hypothalamo-Hypophyseal System/metabolism , Hypothalamo-Hypophyseal System/physiopathology , Male , Neurons/drug effects , Neurons/metabolism , Pituitary-Adrenal System/drug effects , Pituitary-Adrenal System/metabolism , Pituitary-Adrenal System/physiopathology , Rats , Rats, Sprague-Dawley , Receptors, Glucocorticoid/drug effects , Serotonin/metabolism , Selective Serotonin Reuptake Inhibitors/pharmacology , Stress Disorders, Post-Traumatic/drug therapy , Stress Disorders, Post-Traumatic/metabolism , Stress Disorders, Post-Traumatic/physiopathology , Stress, Psychological/drug therapy , Stress, Psychological/physiopathology
11.
Clin Anat ; 18(6): 397-403, 2005 Sep.
Article in English | MEDLINE | ID: mdl-16015654

ABSTRACT

The morphology of the anterior and posterior internal vertebral venous plexus (IVVP) in human fetuses between 21-25 weeks of gestational age is described. The results are compared to the findings of a previous morphological study of the IVVP in the aged. The morphological pattern of the anterior IVVP in the fetus is very similar with the anterior IVVP in the aged human. In contrast, the posterior IVVP in the fetus lacks the prominent transverse bridging veins that are present in the aged lower thoracic and the lumbar posterior IVVP. The background of these morphological differences is unclear. Maybe the thoracolumbar part of the posterior IVVP is subject to "developmental delay," or the observed differences in the aged may result from functional and age-related factors that trigger this part of the vertebral venous system during (erect) life. The observed age related morphological differences of the posterior IVVP support the concept of the venous origin of the spontaneous spinal epidural hematoma (SSEH).


Subject(s)
Fetal Development , Fetus/blood supply , Hematoma, Epidural, Spinal , Spine/blood supply , Veins/embryology , Adult , Aged , Aged, 80 and over , Cadaver , Female , Gestational Age , Hematoma, Epidural, Spinal/etiology , Hematoma, Epidural, Spinal/pathology , Humans , Male , Middle Aged , Spine/embryology , Thorax
12.
Cardiovasc J S Afr ; 16(1): 15-20, 2005.
Article in English | MEDLINE | ID: mdl-15778770

ABSTRACT

The primary objective of this cadaveric study was to review the morphological variations of the anatomy of the human carotid artery bifurcation relevant to carotid endarterectomy (CEA) and carotid artery stent-supported angioplasty (CSSA). We quantify carotid bifurcation plaque morphology. Results showed that the angle of deviation at the origin of the internal carotid artery (ICA), in relation to the common carotid artery (CCA), measured a mean of 21.8 degrees with a range from seven to 45 degrees. This anatomical finding is important for the interventionalist concerned with insertion of a carotid stent. The angle of the ICA origin may be an independent risk factor for early atherosclerotic changes at the ICA bulb. Carotid bifurcation plaque was observed in a small, random cohort of seven out of 13 cadavers, and contributed to a mean stenosis of 15.2% (range 5.0-34.8%). Plaque morphology (n = 7) showed haemorrhage (29%), superficial thrombosis (57%), calcification (71%), areas of focal necrosis (71%), neovascularisation (14%) and infiltrates (29%). Ulcerations were not detected. Although four out of 13 patients (31%) died of a cerebrovascular accident, the cause of cerebral apoplexy was thought not to be associated with the carotid bifurcation pathology. 'Re-boring' of occluding plaque, as in CEA, offers potential volumetric anatomical advantage over CSSA within the carotid bifurcation and bulb. In conclusion, precise and applied knowledge of carotid bifurcation anatomy is critical to reduce technical complications during CEA or CSSA. This information may reduce potential dangers of iatrogenic thrombo-embolism and ensuing neurologic deficits. Patients with low-grade carotid stenosis, evidence of focal plaque necrosis, are at risk of spontaneous plaque cap rupture, distal thromboembolism and stroke.


Subject(s)
Carotid Stenosis/therapy , Aged , Aged, 80 and over , Angioplasty, Balloon , Carotid Artery, Internal/anatomy & histology , Carotid Stenosis/surgery , Endarterectomy, Carotid , Female , Humans , Male , Middle Aged , Stents
13.
Biochem Biophys Res Commun ; 326(4): 699-702, 2005 Jan 28.
Article in English | MEDLINE | ID: mdl-15607725

ABSTRACT

Transcription factors play an important role during pancreatic development ensuring normal differentiation of the islet endocrine cells. In mature beta-cells, expression of specific transcription factors is essential in maintaining normal beta-cell function.


Subject(s)
Diabetes Mellitus, Type 2/metabolism , Islets of Langerhans/growth & development , Islets of Langerhans/metabolism , Pancreas/growth & development , Pancreas/metabolism , Transcription Factors/metabolism , Animals , Cell Differentiation , Diabetes Mellitus, Type 2/pathology , Gene Expression Regulation, Developmental , Humans , Islets of Langerhans/pathology , Pancreas/embryology , Pancreas/pathology
SELECTION OF CITATIONS
SEARCH DETAIL
...